Journal
NEUROSCIENCE LETTERS
Volume 506, Issue 2, Pages 175-179Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.neulet.2011.10.075
Keywords
6-Hydroxydopamine (6-OHDA); Urate; Oxidative stress; Parkinson's disease
Categories
Funding
- Suzhou Foundation for Development of Science, Technology [200815404]
- Jiangsu Ordinary University [08KJB320012]
- Natural Science Foundation of Jiangsu Province, China [BK2010229]
Ask authors/readers for more resources
There is evidence to support that oxidative stress is increased in Parkinson's disease (PD) and contributes to the degeneration of dopaminergic neurons. Recent research has shown that higher blood urate concentrations have now been linked to decreased risks and progression rates of PD. However, the mechanisms about urate to protect dopaminergic neurons are less clear. Our study investigated the effect of urate on oxidative stress induced by 6-hydroxydopamine (6-OHDA) in neuronal differentiated PC12 cells. We found that urate significantly reduced 6-OHDA-induced lactate dehydrogenas (LDH), malondialdehyde (MDA), and 8-hydroxy-deoxyguanosine (8-OHdG) generation but increased the superoxide dismutase (SOD) activity and glutathione (GSH) levels in the PC12 cells. These results suggested that urate can prevent PC12 cells from oxidative injury induced by 6-OHDA, which may play an important role in the mechanisms underlying the association of high plasma levels of urate with reduced risk and slower progression of PD. Urate treatment could be a potential therapeutic strategy for PD. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available